Literature DB >> 11369506

New evidence that the Alzheimer beta-amyloid peptide does not spontaneously form free radicals: an ESR study using a series of spin-traps.

S Turnbull1, B J Tabner, O M El-Agnaf, L J Twyman, D Allsop.   

Abstract

The direct formation of free radicals from Abeta has been suggested to be a key neurotoxic mechanism in Alzheimer's disease (AD). We have explored the possibility of the spontaneous formation of peptide-derived free radicals during the incubation of Abeta 1-40 by ESR spectroscopy using N-tert-butyl-alpha-phenylnitrone (PBN), 5,5-dimethyl-1-pyrroline N-oxide (DMPO), alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone (POBN), and 3,5-dibromo-4-nitrosobenzenesulfonic acid sodium salt (DBNBS) as spin traps. Employing PBN, we observed spectra during the incubation of beta-amyloid peptide, at 37 degrees C, which included adducts of 2-methyl-2-nitrosopropane (MNP), despite rigorous purification of the PBN before incubation. The formation of some of these adducts was found to be enhanced by ambient laboratory light. Our experiments have led us to propose a hypothesis that PBN undergoes hydrolysis and decomposition in the presence of oxidants, which explains the origin of all of the PBN and MNP adducts observed (even when the PBN is highly purified). Hydrogen peroxide, formed during incubation, could play a major role as an oxidant in these experiments. Of the other three spin traps, only DMPO gave (very weak) spectra, but these could be assigned to its hydroxyl radical adduct, formed as an artifact by the nucleophilic addition of water to DMPO, catalyzed by trace levels of iron ions. Thus, while spectra are observed during our experiments, none of them can be assigned to adducts of radicals derived from the peptide and, therefore, our data do not support the suggestion that radicals are spontaneously formed from beta-amyloid peptide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369506     DOI: 10.1016/s0891-5849(01)00510-x

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

Review 1.  Alzheimer's disease & metals: therapeutic opportunities.

Authors:  Vijaya B Kenche; Kevin J Barnham
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

2.  Endogenous zinc in neurological diseases.

Authors:  Jae-Yong Koh
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

3.  Hydroxyl radical oxidation of guanosine 5'-triphosphate (GTP): requirement for a GTP-Cu(II) complex.

Authors:  Giselle Cerchiaro; Celeste Bolin; Fernando Cardozo-Pelaez
Journal:  Redox Rep       Date:  2009       Impact factor: 4.412

4.  Copper enhances amyloid-beta peptide neurotoxicity and non beta-aggregation: a series of experiments conducted upon copper-bound and copper-free amyloid-beta peptide.

Authors:  Xueling Dai; Yaxuan Sun; Zhaolan Gao; Zhaofeng Jiang
Journal:  J Mol Neurosci       Date:  2009-08-14       Impact factor: 3.444

Review 5.  Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.

Authors:  Mattia Toni; Maria L Massimino; Agnese De Mario; Elisa Angiulli; Enzo Spisni
Journal:  Front Neurosci       Date:  2017-01-19       Impact factor: 4.677

Review 6.  The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease.

Authors:  Simon C Drew
Journal:  Front Neurosci       Date:  2017-06-02       Impact factor: 4.677

Review 7.  Simultaneous exposure to noise and carbon monoxide increases the risk of Alzheimer's disease: a literature review.

Authors:  Fereshteh Bagheri; Vahid Rashedi
Journal:  Med Gas Res       Date:  2020 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.